Ignite Creation Date:
2025-12-24 @ 2:27 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT00303459
Status:
COMPLETED
Last Update Posted:
2025-02-04
First Post:
2006-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Sponsor:
Actelion
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pulmonary Arterial Hypertension | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | sildenafil | View |
| None | Combination Drug Therapy | View |
| None | bosentan | View |
| None | Pulmonary Hypertension | View |
| None | Pulmonary Arterial Hypertension | View |
| None | Multicenter Study | View |
| None | Antihypertensive Agents | View |
| None | Tracleer | View |
| None | endothelin receptor antagonist | View |
| None | Randomized Controlled Trial | View |
| None | Phosphodiesterase type 5 inhibitor (PDE5i) | View |
| None | Outcome Assessment | View |